Cargando…
Correction: Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283657/ https://www.ncbi.nlm.nih.gov/pubmed/28141850 http://dx.doi.org/10.1371/journal.pntd.0005328 |
Ejemplares similares
-
Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
por: Dauchy, Frédéric-Antoine, et al.
Publicado: (2016) -
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010) -
Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
por: Gunatilleke, Shamila S., et al.
Publicado: (2012) -
Correction: Knockdown of Asparagine Synthetase A Renders Trypanosoma brucei Auxotrophic to Asparagine
por: Loureiro, Inês, et al.
Publicado: (2013) -
Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi
por: Habila, Nathan, et al.
Publicado: (2010)